Literature DB >> 25439053

Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.

D Sartini1, L Lo Muzio, S Morganti, V Pozzi, G Di Ruscio, R Rocchetti, C Rubini, A Santarelli, M Emanuelli.   

Abstract

OBJECTIVES: Oral squamous cell carcinoma (OSCC) represents about 90% of all oral neoplasms with a poor clinical prognosis. To improve survival of OSCC patients, it is fundamental to understand the basic molecular mechanisms characterizing oral carcinogenesis. Dysregulation of oncogenes and tumor suppressor genes seems to play a central role in tumorigenesis, including malignant transformation of the oral cavity.
MATERIALS AND METHODS: We analyzed the expression levels of the pro-oncogenic transcription factor Pokemon through real-time PCR, Western blot and immunohistochemistry in tumor, and normal oral tissue samples obtained from 22 patients with OSCC. The relationship between tumor characteristics and the level of Pokemon intratumor expression was also analyzed.
RESULTS: Pokemon was significantly downregulated in OSCC. In particular, both mRNA and protein levels (tumor vs normal tissue) inversely correlated with histological grading, suggesting its potential role as a prognostic factor for OSCC. Moreover, a significant inverse correlation was found between Pokemon protein expression levels (OSCC vs normal oral mucosa) and tumor size, supporting the hypothesis that Pokemon could play an important role in the early phase of tumor expansion.
CONCLUSION: This work shows that reduced expression of Pokemon is a peculiar feature of OSCC. Additional studies may establish the effective role of Pokemon in oral tumorigenesis.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Pokemon; histological grading; oral cancer; tumor size; tumorigenesis

Mesh:

Substances:

Year:  2015        PMID: 25439053     DOI: 10.1111/odi.12304

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  6 in total

1.  MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.

Authors:  Min Zhu; Mingyang Li; Tao Wang; Enqiang Linghu; Benyan Wu
Journal:  Tumour Biol       Date:  2016-08-04

2.  miR-29b inhibits non-small cell lung cancer progression by targeting STRN4.

Authors:  Yuping Xie; Fen Zhao; Ping Zhang; Ping Duan; Yangmei Shen
Journal:  Hum Cell       Date:  2019-12-07       Impact factor: 4.174

3.  Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Authors:  Yingying Shen; Renxian Cao; Wen Liu; Yuqing Zhou; Ying Wu; Jingjing Tan; Min Jin; Jing Zhong; Qinghai Zhang; Jianghua Liu; Xuyu Zu
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

4.  Prognostic value of nuclear FBI-1 in patients with rectal cancer with or without preoperative radiotherapy.

Authors:  Chao-Jie Wang; Chu-Rui Chao; Hui-Min Liu; Yan-Yan Zhu; Gunnar Adell; Ingvar Jarlsfelt; Hong Zhang; Xiao-Feng Sun
Journal:  Oncol Lett       Date:  2019-09-19       Impact factor: 2.967

5.  The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma.

Authors:  Li-Yin Yeh; Cheng-Chieh Yang; Hsiao-Li Wu; Shou-Yen Kao; Chung-Ji Liu; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Front Oncol       Date:  2020-01-31       Impact factor: 6.244

6.  Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells Via Activation of the LKB1/AMPK Pathway.

Authors:  Tingting Li; Yong Tian; Yixuan Wang; Zhen Cui; Zelai He; Xiao Wu; Yajun Zhang; Hao Jiang
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.